Jacobs Levy Equity Management, Inc Organogenesis Holdings Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 48,613 shares of ORGO stock, worth $292,164. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,613
Previous 281,478
82.73%
Holding current value
$292,164
Previous $805,000
80.75%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ORGO
# of Institutions
124Shares Held
62MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$75 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$71.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$30.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$21.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$18.5 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $787M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...